Table 2.

Univariate logistic regression analysis for cardiovascular autonomic neuropathy.

Variable	β	SE	P value	OR	95% CI
Age	0.042	0.007	<0.001	1.04	1.029–1.103
Gender	0.176	0.117	0.134	1.19	0.947–1.547
BMI	0.066	0.016	<0.001	1.07	1.034–1.046
WC	0.034	0.006	<0.001	1.03	1.023–1.024
SBP	0.018	0.003	<0.001	1.02	1.012–1.030
DBP	0.019	0.006	0.001	1.02	1.007–1.261
Smoking	0.133	0.155	0.390	1.14	0.843–2.733
MetS	0.646	0.114	<0.001	1.91	1.527–1.307
HT	0.779	0.116	<0.001	2.18	1.736–3.248
HR	0.952	0.068	<0.001	2.59	2.267–2.565
DM	0.936	0.123	<0.001	2.55	2.003–3.156
DM-HR	0.487	0.033	<0.001	1.63	1.525–1.737
FPG	0.178	0.027	<0.001	1.19	1.133–1.149
PBG	0.111	0.014	<0.001	1.12	1.087–1.722
HbAlc	0.392	0.077	<0.001	1.48	1.271–1.026
FINS	0.014	0.006	0.015	1.01	1.003–1.159
IR	0.091	0.029	0.001	1.10	1.036–1.212
TC	0.082	0.056	0.142	1.09	0.973–1.369
TG	0.213	0.051	<0.001	1.24	1.119–1.129
HDL	−0.225	0.177	0.203	0.80	0.564–1.259
LDL	0.088	0.073	0.229	1.09	0.946–1.005
UA	0.001	0.001	0.216	1.00	0.999–1.108

Note: CAN: cardiovascular autonomic neuropathy; β: regression coefficient; SE: standard error; OR: odds ratio; CI: confidence interval; BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; PBG: plasma blood glucose; FINS: fasting blood insulin; IR: insulin resistance; TC: serum total cholesterol; TG: triglyceride; UA: uric acid; HDL: high-density lipoprotein cholesterol; LDL: low density lipoprotein cholesterol; SCr: serum creatinine; HR: heart rate; MetS: metabolic syndrome; HT: hypertension; DM: diabetes.